Skip to Content

WATSON 657 (Buspirone 5 mg)

Pill imprint WATSON 657 has been identified as Buspirone hydrochloride 5 mg.

Buspirone is used in the treatment of sexual dysfunction, ssri induced; anxiety; panic disorder and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. There is no proven risk in humans during pregnancy. Buspirone 5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Buspirone hydrochloride 5 mg WATSON 657 Front
Buspirone hydrochloride 5 mg WATSON 657 Back
Buspirone hydrochloride 5 mg WATSON 657
Buspirone hydrochloride 5 mg WATSON 657
Buspirone hydrochloride
5 mg
8.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide colloidal
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0028 Amerisource Health Services
63739-0319 McKesson Packaging Services
68115-0053 Dispensexpress Inc (repackager)
21695-0256 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.